HS Code 30043110 — Insulin preparations, put up for retail sale

HS code 30043110 refers to "Insulin preparations, put up for retail sale" under Chapter 30 (Pharmaceutical Products), Heading 3004 (Medicaments put up in measured doses or for retail sale) of the Harmonized System. In India's export trade, this code covers $459.2B in trade value across 3,213 shipments from 49 exporters to 56 countries.

13 distinct pharmaceutical products are exported from India under HS code 30043110. The top products include Insulin ($459.2B), Zinc ($384.6K), Vati ($348.5K). These cover a combined trade value of $459.2B.

The top importing countries for HS code 30043110 from India are United States ($87.8M), Netherlands ($70.2M), Australia ($26.5M), Thailand ($21.7M), United Kingdom ($18.8M). In total, Indian exporters ship products under this code to 56 countries worldwide.

The leading Indian exporters under HS code 30043110 include M/S. NOVO NORDISK A/S ($228.5B), SANOFI-AVENTIS SINGAPORE PTE LTD ($152.6B), ELI LILLY EXPORT S.A ($61.4B). In total, 49 Indian exporters ship products under this classification.

Import duties for HS code 30043110 (Insulin preparations, put up for retail sale) vary by destination country. As a Chapter 30 pharmaceutical product, many countries offer preferential or zero-duty rates for essential medicines under this code. The average transaction value from India is $142.9M, and importers should consult their national customs authority for applicable duty rates, exemptions, and regulatory requirements.